DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Metelimumab
Metelimumab
Fig. L COMPOSITIONS and METHODS to INHIBIT STEM CELL and PROGENITOR CELL BINDING to LYMPHOID TISSUE and for REGENERATING GERMINAL CENTERS in LYMPHATIC TISSUES
Medical Therapy of Stricturing Crohn's Disease
Modifications to the Harmonized Tariff Schedule of the United States To
The Two Tontti Tudiul Lui Hi Ha Unit
Selectively Targeting TGF-Β with Trabedersen/OT-101 in Treatment of Evolving and Mild ARDS in COVID-19
Ep 3178848 A1
I Regulations
(INN) for Biological and Biotechnological Substances
Transforming Growth Factor-β in Stem Cells and Tissue Homeostasis
WO 2012/162592 Al 29 November 2012 (29.11.2012) P O P C T
INN Working Document 05.179 Update 2011
INN Working Document 05.179 Update December 2010
Customs Tariff - Schedule
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
(12) Patent Application Publication (10) Pub. No.: US 2017/0143845 A1 Zhao (43) Pub
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
Top View
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
VIEW Open Access Recent Advances in the Treatment of Skin Involvement in Systemic Sclerosis Yoshihide Asano
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
(12) United States Patent (10) Patent No.: US 9,682,071 B2 Nicols Et Al
Wo 2010/095940 A2
Customs Tariff - Schedule Xxi - 1
Recent Advances in the Development of TGF-Β Signaling Inhibitors for Anticancer Therapy
Therapeutic Implications of Tgfβ in Cancer Treatment: a Systematic Review
WO 2012/160186 Al 29 November 2012 (29.11.2012) P O P C T
Selectively Targeting TGF-Β with Trabedersen/OT-101 in Treatment of Evolving and Mild Ards in COVID-19
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
(INN) for Biological and Biotechnological Substances
Targeting the Tgfβ Signalling Pathway in Disease
Thalidomide - Wikipedia, the Free Encyclopedia
Scleroderma: an Insight Into Causes, Pathogenesis and Treatment Strategies
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
TGF- Pathway in Salivary Gland Fibrosis